Table 6. Data on aortic stent grafts and fenestrated stent graft utility.
References | Stented vessels: RRA/LRA/SMA/CA | Main Stents | Fenestrated stent grafts |
---|---|---|---|
Lee et al. 201438 | Stented vessels: 25 | 15 ZFENb1 | Covered stents: |
25 iCASTc | |||
Globalstar 201218 | Target vessels: 889 | 318 Zenithb4 | Bare metal stents: 63 vessels |
Stented vessels: 670. | 35 Palmaz Genesish1. | ||
RRA/LRA/SMA/CA | 13 EV3k | ||
269/278/113/10 | 7 Luminexxd2 | ||
2 AVEe1 | |||
1Expressf1 | |||
5 unspecified bare stents | |||
Covered stents :529 vessels | |||
522 Advantac | |||
4 Jostenti | |||
3 Fluencyd2 | |||
78 unspecified covered stents. | |||
Liao et al. 201439 | Target vessels: 21 | 8 Zenithb1 | Covered balloon-expandable stents: |
Stented vessels: 8 | 8 iCASTc | ||
Dijkstra et al. 201440 | Stented vessels: 56 | 25 Anacondam | Covered stents for all renal artery |
54 Advanta V12c | |||
2 unspecified bare stents | |||
Donas et al. 201231 | Stented vessels: 44 | 29 Zenithb1 | Covered balloon expandable |
32 Advantac | |||
Bare balloon expandable | |||
12 Palmazh1 | |||
Suominen et al. 201332 | Target vessels: 54 | 21 Zenithb2 | Covered stents : |
Stented vessels: 49 | 49 Advanta V12c | ||
RRA/LRA/SMA | |||
17/16/21 | |||
Greenberg et al. 200941 | Target vessels: 77 | 30 Zenithb1 | N.D. |
Stented vessels: 54 | |||
Tambyraja et al. 201142 | Target vessels: 79 | 29 Cook Zenithb3 | 29 unspecified covered stent |
18 unspecified bare stent | |||
2 unspecified stent | |||
Stented vessels: 49 | |||
Oderich et al. 201443 | Target vessels: 178 | 67 Zenithb1 | 58 Zenith alignment stentb1 |
Stented vessels: 127 | |||
29 Express LD stentf1 | |||
25 eV3 IntraTherapeutics stentk2 | |||
20 iCAST Covered stentc | |||
2 Palmaz Genesis stenth2 | |||
1 Bridge Assurant stent e1 |
a1. W. L. Gore and Associates, Newark, DE, U.S. a2. W. L. Gore, Flagstaff, AZ, U.S. b1 .Cook Inc, Bloomington, IN, U.S. b2. Cook Australia Ltd, Australia. b3. William A. Cook Australia, Ltd., Brisbane, Australia b4. Cook Medical, Canvey Island, U.K. c Atrium Medical Corporation, Hudson, NH, U.S. d1. C.R. Bard, Murray Hill, NJ, U.S. d2. Bard Peripheral Vascular, Inc.US e1. Medtronic, Inc, Minneapolis, MN, U.S. e2. Medtronic Vascular, Santa Rosa, CA, U.S. f1. Boston Scientific, Natick, MA, U.S. f2. Boston Scientific, Bloomington, MN, U.S. g Endologix, Inc, Irvine, CA,U.S. h1 Cordis Corporation, Johnson & Johnson Company, Miami, FL, U.S. h2. Cordis, Warren, NJ, U.S. i Abbott Vascular, Temecula, CA, U.S. j Biltronic, Bulach, Switzerland. k1 ev3Endovascular Inc, Plymouth, MN, U.S. k2. Covidien, Plymouth, CA, U.S. l Ovation; TriVascular Inc., Santa Rosa, CA, U.S. m. Vascutek, Renfrewshire, Scotland, U.K.